Neuronostics has raised £3 million, with Empirical Ventures, to scale BioEP, its clinical decision-support tool for epilepsy diagnosis.
Neuronostics' cloud-based BioEP analyses EEG recordings to support faster, more confident epilepsy diagnosis.
The new capital will help the team accelerate development and bring the technology closer to market.
